BioInvent Announces Selection of Second Target and Extension of the Research Collaboration and License Agreement With Pfizer Inc.

23. Dezember 2019 INDIZES WEUR

LUND, Sweden, Dec. 23, 2019 /PRNewswire/ — BioInvent International AB (“BioInvent” or the “Company”) (OMXS: BINV) today announces that Pfizer Inc. (“Pfizer”) (NYSE: PFE) has selected the second …
(Orginal – Story lesen…)

Tags: atx cac ftse ibex omxs wig-20

You may also like...